SCHEMBL18409258

SCHEMBL18409258

CCCc1ccc(CN(C(=O)C2CC2)c2nc(Cl)cc3c2ncn3C)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 3/20 0.38
S1PR5 Q9H228 2/20 0.36
SMN1; SMN2 Q16637 5/20 0.36
KDM4E B2RXH2 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35
PTGDR2 Q9Y5Y4 5/20 0.35
S1PR4 O95977 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
CYP3A4 P08684 1/20 0.34
PTGDR Q13258 1/20 0.34
CXCR3 P49682 4/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409112 0.89 KMT2A (0.40) SMN1; SMN2KDM4ENPSR1L3MBTL1HTT
SCHEMBL18409259 0.81 MEN1 (0.40) SMN1; SMN2KDM4EMEN1GAAKMT2A
SCHEMBL18409277 0.81 JAK2 (0.37) S1PR1S1PR5NR1H4
SCHEMBL18409179 0.79 SLC6A2 (0.36) KDM4EMEN1GAAKMT2ALMNA
SCHEMBL18409115 0.78 POLB (0.40) SMN1; SMN2KDM4EHTTMEN1GAA
SCHEMBL18409326 0.75 JAK2 (0.41) SMN1; SMN2KDM4EMEN1GAAKMT2A
SCHEMBL18409113 0.75 ALDH1A1 (0.36) KDM4ENPSR1MEN1KMT2AALDH1A1
SCHEMBL18409110 0.74 POLB (0.33) KDM4EMEN1KMT2ALMNAPTGDR2
SCHEMBL18409118 0.73 CCNE2 (0.36) SMN1; SMN2KDM4ENPSR1L3MBTL1HTT
SCHEMBL18409291 0.73 JAK2 (0.37) KDM4EMEN1KMT2ANR1H4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 WO disclosed